Patents by Inventor Stevin H. Zorn

Stevin H. Zorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dopamine D4 ligands for the treatment of novelty-seeking disorders
    Publication number: 20040116443
    Abstract: The present invention provides a method of treating or preventing a novelty-seeking disorder such as pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction, drug addiction, alcohol addiction and sex addiction, using a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 9, 2003
    Publication date: June 17, 2004
    Applicant: Pfizer Inc
    Inventors: Stevin H. Zorn, Mark A. Sanner, Anton F. Fliri, Patricia A. Seymour
  • Dopamine D4 ligands for the treatment of novelty-seeking disorders
    Publication number: 20030158208
    Abstract: The present invention provides a method of treating or preventing a novelty-seeking disorder such as pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction, drug addiction, alcohol addiction and sex addiction. using a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 10, 2003
    Publication date: August 21, 2003
    Applicant: Pfizer Inc.
    Inventors: Stevin H. Zorn, Mark A. Sanner, Antor F. Fliri, Patricia A. Seymour
  • Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas
    Patent number: 6608064
    Abstract: The present invention is directed to the use of certain pyrido[1,2-a]-pyrazine derivatives, also described as bis-azabicyclic compounds and defined by the formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorder and microadenomas in mammals, and to related compositions.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: August 19, 2003
    Assignee: Pfizer Inc
    Inventors: Stafford McLean, Stevin H. Zorn, Elisa R. Jackson
  • Dopamine D4 ligands for the treatment of novelty-seeking disorders
    Patent number: 6548502
    Abstract: The present invention provides a method of treating or preventing a novelty-seeking disorder, such as pathological gambling, attention deficit disorder with hyperactivity disorder and sex addiction, comprising administering a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: April 15, 2003
    Assignee: Pfizer Inc
    Inventors: Stevin H. Zorn, Mark A. Sanner, Antor F. Fliri, Patricia A. Seymour
  • Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease
    Publication number: 20020052373
    Abstract: The present invention relates to a method of treating dementia or cognitive deficits associated with Alzheimer's Disease or Parkinson's Disease in a mammal, including a human, by administering to the mammal a D4 dopamine receptor in combination with an acetylcholine esterase inhibitor. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a D4 dopamine receptor and an acetylcholine esterase inhibitor.
    Type: Application
    Filed: August 16, 2001
    Publication date: May 2, 2002
    Inventors: Stevin H. Zorn, Mark A. Sanner, Anton F.J. Fliri
  • Dopamine D4 ligands for the treatment of novelty-seeking disorders
    Publication number: 20020049209
    Abstract: The present invention provides a method of treating or preventing a novelty-seeking disorder such as pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction, drug addiction, alcohol addiction and sex addiction. using a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 26, 2001
    Publication date: April 25, 2002
    Inventors: Stevin H. Zorn, Mark A. Sanner, Antor F. Fliri, Patricia A. Seymour
  • Pharmaceutical agents for the treatment of parkinson's disease, ADHD and microadenomas
    Publication number: 20010034347
    Abstract: The present invention is directed to the use of certain pyrido[1,2-a]-pyrazine derivatives, also described as bis-azabicyclic compounds and defined by the formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorder and microadenomas in mammals, and to related compositions.
    Type: Application
    Filed: May 3, 2001
    Publication date: October 25, 2001
    Inventors: Stafford McLean, Stevin H. Zorn, Elisa R. Jackson
  • Benzimidazole derivatives having dopaminergic activity
    Patent number: 5889010
    Abstract: Pharmaceutically active benzimidazole derivatives are disclosed comprising compounds of the formula: ##STR1## particularly wherein X is nitrogen, R.sup.1 is phenyl or heteroaryl, and one of R.sup.2 or R.sup.3 is hydroxy.
    Type: Grant
    Filed: January 31, 1997
    Date of Patent: March 30, 1999
    Assignee: Pfizer Inc.
    Inventors: William S. Faraci, Anton F. J. Fliri, Brian T. O'Neill, Mark A. Sanner, Stevin H. Zorn
  • Benzimidazolone derivatives with central dopaminergic activity
    Patent number: 5883094
    Abstract: This invention relates to novel, pharmaceutically active benzimidazolone derivatives of the formula ##STR1## wherein the dashed line, R.sup.0 through R.sup.6 and X.sup.1 through X.sup.3 are defined as in the specification. These compounds exhibit central dopaminergic activity and are u in the treatment of CNS disorders.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: March 16, 1999
    Assignee: Pfizer Inc.
    Inventors: Anton F-J. Fliri, Brian T. O'Neill, William S. Faraci, Mark A. Sanner, Stevin H. Zorn